Thu 25 April 2024
Warszawa (PL)
7/2°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
11 |
8 |
11 |
14 |
20 |
Thu 25 April 2024
Praha (CZ)
4/-1°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
11 |
10 |
12 |
15 |
21 |
Thu 25 April 2024
Bratislava (SK)
3/4°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
11 |
10 |
13 |
16 |
18 |
Thu 25 April 2024
Budapest (HU)
7/1°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
16 |
11 |
13 |
17 |
21 |
February 8th, 2021
The Health Ministry will recommend the use of the drugs for COVID-19 based on monoclonal antibodies, namely kasirivimab and imdevimab from the Regeneron firm and bamlanivimab from the Eli Lilly firm, it said in a press release today. These drugs are suitable for people with a high risk of severe symptoms of the infection disease, for example patients after transplants. The target groups are yet to be defined.
CTK
Pageviews this month:
38,708